ML18025B121

From kanterella
Jump to navigation Jump to search
Official Exhibit - NRC-010-MA-CM01 - Staff Presentation Slides - Overview (Jan. 16, 2018)
ML18025B121
Person / Time
Site: Northwest Medical Isotopes
Issue date: 01/16/2018
From:
NRC/OGC
To:
NRC/OCM
SECY RAS
References
50-609-CP, Construction Permit Mndtry Hrg, RAS 54173
Download: ML18025B121 (18)


Text

Northwest Medical Isotopes Construction Permit Application Review

  • Mandatory Hearing (Overview Panel)
  • January 23, 2018 NRC-010 United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of:

NORTHWEST MEDICAL ISOTOPES, LLC (Medical Radioisotope Production Facility)

Commission Mandatory Hearing Docket #: 05000609 Exhibit #:

Identified:

Admitted:

Withdrawn:

Rejected:

Stricken:

Other:

NRC-010-MA-CM01 1/23/2018 1/23/2018

Panelists

-Deputy Director for Reactor Safety Programs and Mission Support, NRR

  • MaryJane Ross-Lee

-Deputy Director, NRR/DLP

-Deputy Director, NRR/DMLR

- Deputy Director, NMSS/FCSE 2

99Mo Overview

  • 99Mo decays to 99mTc

-Effective diagnosis

-Minimal exposure

  • 50,000 procedures daily
  • No domestically-produced supply 3

Establishing a Domestic Supply of 99Mo

  • NRC supports U.S. policy objectives to establish domestic 99Mo production
  • First construction permit for domestic 99Mo production issued to SHINE Medical Technologies in 2016
  • Northwest Medical Isotopes would produce 99Mo by processing irradiated low enriched uranium targets 4

Conducting the NWMI Review

  • Review of NWMI application supported by procedural efficiencies and previous licensing experience

-Two-part application submission

-Document templates

-Permit condition supporting quality assurance implementation

  • Staff and contractors spent ~12,000 hours0 days <br />0 hours <br />0 weeks <br />0 months <br /> reviewing NWMI application 5

Authorizing Construction

  • NWMI seeks authorization to construct 10 CFR Part 50 production facility
  • Staff review based on preliminary design and analysis of facility

-Design details may be left for operating license application

-Target fabrication activities to be considered under a 10 CFR Part 70 application 6

Conducting the Safety Review 7

Environmental Review ACRS Review Mandatory Hearing Application Submitted to NRC Commission Decision on Permit Safety Review

Tailoring Review Methodology

  • Review accommodated unique aspects of the NWMI application
  • Staff adapted existing guidance for research reactors, production facilities, and fuel cycle facilities
  • Review focused on whether there was reasonable assurance that the final design would conform to design bases 8

Additional Information

  • In response to staff requests, NWMI provided additional information
  • In some cases, permit conditions were necessary to support findings

Environmental Requirements

  • National Environmental Policy Act

- Informs Federal decision making

-Public disclosure

- NRC regulations implementing the National Environmental Policy Act 1

0

Environmental Review Process Environmental Site Audit Draft Environmental Impact Statement Scoping

  • Comment Period *
  • Opportunity for Public Involvement Final Environmental Impact Statement Environmental Report Request for Additional Information 1

1

Proposed Discovery Ridge Site 1

2

  • Agricultural land
  • Previously disturbed
  • No surface water features
  • No threatened or endangered species
  • No historical or cultural resources

Statutory and Regulatory Basis for Construction Permit Issuance

  • Commission authorized to issue permits by Atomic Energy Act, Section 103

3

Construction Permit Findings

  • Preliminary facility design described
  • Further technical or design information may be left for FSAR
  • Ongoing research and development identified
  • Facility can be constructed and operated without undue risk 1

4

Construction Permit Considerations

  • Construction will not endanger public health and safety
  • NWMI is technically and financially qualified
  • Environmental requirements have been satisfied 1

5

Introducing the Review Panels 1

6 Panel Number Discussion Topics Evaluation Areas Safety Panel 1 Licensing Considerations Safety Evaluation Report Chapters 1, 4, and 12 Safety Panel 2 Accident Analysis Methodology Safety Evaluation Report Chapter 13 Environmental Panel Final Environmental Impact Statement Process Scope and Connected Actions Analysis of Alternatives Final Environmental Impact Statement

Acronyms

- Office of Nuclear Reactor Regulation

  • DLP

- Division of Licensing Projects

  • NMSS - Office of Nuclear Material Safety and Safeguards
  • FCSE - Division of Fuel Cycle Safety, Safeguards, and Environmental Review 1

7

Acronyms

  • 99Mo - molybdenum-99
  • 99mTc - technetium-99m
  • NRC

- U.S. Nuclear Regulatory Commission

  • NWMI - Northwest Medical Isotopes
  • CFR

- Code of Federal Regulations

  • FSAR - final safety analysis report 1

8